Astrazeneca Pharma India Ltd (ASTR.NS)

ASTR.NS on National Stock Exchange of India

1,052.25INR
17 Apr 2014
Price Change (% chg)

Rs-0.50 (-0.05%)
Prev Close
Rs1,052.75
Open
Rs1,059.40
Day's High
Rs1,064.80
Day's Low
Rs1,041.10
Volume
6,937
Avg. Vol
77,823
52-wk High
Rs1,286.00
52-wk Low
Rs634.00

ASTR.NS

Chart for ASTR.NS

About

AstraZeneca Pharma India Limited is a pharmaceutical company. The Company operates in three segments: healthcare, clinical trial services and co-promotional services. The healthcare segment is engaged in the manufacture and sale of pharmaceutical products. The clinical trial services segment offers clinical trial services on... (more)
No analyst recommendations are available for ASTR.NS.

Overall

Beta: 0.78
Market Cap (Mil.): Rs26,306.25
Shares Outstanding (Mil.): 25.00
Dividend: --
Yield (%): --

Financials

  ASTR.NS Industry Sector
P/E (TTM): -- 33.26 33.35
EPS (TTM): -6.59 -- --
ROI: -- 19.66 18.92
ROE: -- 20.35 19.68
Search Stocks

AstraZeneca India unit sets floor price for stock delisting

REUTERS - AstraZeneca Pharma India Ltd , a unit of British drugmaker AstraZeneca Plc , said on Friday the floor price for its delisting from the Indian stock exchanges had been set at 854.1 rupees a share.

11 Apr 2014

AstraZeneca India unit sets floor price for stock delisting

April 11 - AstraZeneca Pharma India Ltd, a unit of British drugmaker AstraZeneca Plc, said on Friday the floor price for its delisting from the Indian stock exchanges had been set at 854.1 rupees a share.

11 Apr 2014

AstraZeneca shares surge; board OKs delisting

Reuters Market Eye - Shares in AstraZeneca Pharma India surge as much as 7.6 percent on Tuesday after the company says its board approved a proposal from promoter AstraZeneca Pharmaceuticals AB, Sweden to delist the company from India.

18 Mar 2014

MARKET EYE-India's AstraZeneca shares surge; board OKs delisting

* Shares in AstraZeneca Pharma India surge as much as 7.6 percent on Tuesday after the company says its board approved a proposal from promoter AstraZeneca Pharmaceuticals AB, Sweden to delist the company from India. * Shares in AstraZeneca are up 47.6 rupees at 1208 at 0601 GMT. The stock hit a 52-week high of 1,286 rupees on March 4, since the company first announced the delisting proposal, and has gained 30.4 percent so far this month. (indulal.p@thomsonreuters.com/indulal.p.thomsonreuters

18 Mar 2014

MARKET EYE-AstraZeneca India plunges; delisting decision delayed

* AstraZeneca Pharma India shares plunge as much as 9.6 percent after its board late on Wednesday deferred a proposal to delist the company from Indian exchanges. * The board deferred the proposal saying it would seek additional information from its promoter AstraZeneca Pharmaceuticals AB (AZP AB) Sweden, which had sought the delisting. * AstraZeneca shares surged 47 percent in the four trading sessions till Tuesday on expectation that the delisting price would be at a substantial premium to th

06 Mar 2014

Astrazeneca India falls on profit-taking after surge

Reuters Market Eye - Shares in Astrazeneca Pharma India Ltd fell as much as 5.02 percent on profit-taking ahead of the company's board meet later in the day to consider a proposal by promoter AstraZeneca Pharmaceuticals AB (AZP AB) Sweden to delist the company.

05 Mar 2014

MARKET EYE-Astrazeneca India falls on profit-taking after surge

* Shares in Astrazeneca Pharma India Ltd fell as much as 5.02 percent on profit-taking ahead of the company's board meet later in the day to consider a proposal by promoter AstraZeneca Pharmaceuticals AB (AZP AB) Sweden to delist the company. * Astrazenaca Pharma India has surged 47 percent in the past 4 trading sessions on expectation that the delisting price would be at a substantial premium to the existing market price of the company. * Shares in the company were down 2.93 percent at 0405 GM

05 Mar 2014

Indian shares snap five-day winning streak on Ukraine fears

* BSE index falls 0.82 pct; NSE ends 0.88 pct lower * India's volatility index marks biggest gain in a month * Institutional investors turn heavy buyers of Indian stocks * Astrazeneca Pharma India surges on delisting proposal By Abhishek Vishnoi MUMBAI, Mar 3 - Indian shares fell on Monday to snap a five-day winning streak as blue-chip stocks including ICICI Bank declined as part of an emerging markets retreat over fears of military tensions between Russia and Ukra

03 Mar 2014

Astrazeneca Pharma India surges on delisting proposal

Reuters Market Eye - Shares in Astrazeneca Pharma India Ltd surge 20 percent to their maximum daily limit after the drug maker says its board would meet on Wednesday to discuss delisting proposal.

03 Mar 2014

MARKET EYE -Astrazeneca Pharma India surges on delisting proposal

* Shares in Astrazeneca Pharma India Ltd surge 20 percent to their maximum daily limit after the drug maker says its board would meet on Wednesday to discuss delisting proposal. * AstraZeneca Pharma India said in the filing before markets opened on Monday that its board received a request from its promoter, AstraZeneca Pharmaceuticals AB (AZP AB) Sweden, to initiate a voluntary delisting process. * Astrazeneca Pharmaceuticals AB holds 75 percent in AstraZeneca Pharma India. (abhishek.vishnoi

03 Mar 2014

Earnings vs. Estimates

No consensus analysis data available.
Search Stocks